Loquiño, Ashley T.

HRN: 23-95-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
AMPICILLIN 250MG (VIAL)
10/24/2023
10/31/2023
IVT
215mg
Q6
PCAP-C
Waiting Final Action 
10/24/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/24/2023
10/31/2023
IVT
45mg
Q24
PCAP-P
Waiting Final Action 
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
190mg
Q8h
Pcap C
Waiting Final Action 
10/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/26/2023
11/01/2023
IVT
57mg
Q8
Amoebiasis Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: